| ROSEN, THE FIRST FILING FIRM, Encourages UP Fintech Holding Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - TIGR |
Globe Newswire |
10/30 |
07:51 |
| Allarity Therapeutics Secures First Commercial Agreement Under New CLIA Laboratory Services Strategy, Establishing Potential Path to Additional Recurring Revenue |
Globe Newswire |
10/30 |
07:45 |
| Caliber Sets Date for Third Quarter 2026 Earnings Announcement & Investor Conference Call |
Globe Newswire |
10/30 |
07:45 |
| CN Delivers Strong Third Quarter Performance |
Globe Newswire |
10/30 |
07:30 |
| MRP INVESTOR DEADLINE: Millrose Properties, Inc. Investors with Substantial Losses May Seek to Lead Class Action Lawsuit Before December 8, 2026 Deadline - RGRD Law |
Globe Newswire |
10/30 |
07:29 |
| Fuzhou to Host Global Observance of World Cities Day 2026 |
Globe Newswire |
10/30 |
07:10 |
| Alterity Therapeutics Releases Appendix 4C – Q1 FY27 Quarterly Cash Flow Report & Corporate Update |
Globe Newswire |
10/30 |
07:05 |
| Pacifica Silver Corp. Begins Trading on OTCQX Best Market |
Globe Newswire |
10/30 |
07:00 |
| NRx Pharmaceuticals (Nasdaq:NRXP) Receives FDA Approval of Preservative-Free Ketamine Ahead of November 10 FDA Goal Date |
Globe Newswire |
10/30 |
07:00 |
| J & J SNACK FOODS SCHEDULES FOURTH QUARTER and FISCAL YEAR EARNINGS CONFERENCE CALL AND WEBCAST |
Globe Newswire |
10/30 |
07:00 |
| Acumen Pharmaceuticals Announces Topline Results from Phase 2 ALTITUDE-AD Clinical Trial of Sabirnetug (ACU193) for the Treatment of Early Alzheimer’s Disease; Trial Did Not Meet Primary Endpoint |
Globe Newswire |
10/30 |
07:00 |
| Fractyl Health Strengthens Revita Patent Portfolio as It Advances Toward FDA Submission and Potential Commercialization |
Globe Newswire |
10/30 |
07:00 |
| Syndax Announces Participation in November Investor Conferences |
Globe Newswire |
10/30 |
07:00 |
| Banco Santander-Chile Reports Strong Third Quarter 2026 Results, Driven by Continued Customer Growth, Higher Profitability and Stable Capital Levels |
Globe Newswire |
10/30 |
07:00 |
| Lightbridge Receives Notice of Allowance for a Korean Patent Covering Its Mixed-Grid Nuclear Fuel Assembly Design |
Globe Newswire |
10/30 |
07:00 |
| Agios Announces New PDUFA Goal Date of February 1, 2027, for Mitapivat Sickle Cell Disease sNDA; Company Is Launch-Ready and in Labeling Discussions with FDA |
Globe Newswire |
10/30 |
07:00 |
| EU Retail Leverage Limits Set Minimum Margin at 5% for Gold CFDs and 10% for Oil |
Globe Newswire |
10/30 |
07:00 |
| Kite Realty Group Reports Third Quarter 2026 Operating Results |
Globe Newswire |
10/30 |
06:45 |
| nVent Electric plc Third Quarter 2026 Financial Results Available on Company’s Website |
Globe Newswire |
10/30 |
06:30 |
| Goliath Resources Closes $9,800,000 Non-Brokered |
Globe Newswire |
10/30 |
06:30 |
| LyondellBasell reports third quarter 2026 earnings |
Globe Newswire |
10/30 |
06:30 |
| Regeneron Reports Third Quarter 2026 Financial and Operating Results |
Globe Newswire |
10/30 |
06:30 |
| LyondellBasell agrees to sell former refinery site in Houston |
Globe Newswire |
10/30 |
06:25 |
| BBNX Lawsuit Reminder: Beta Bionics Hit with Securities Fraud Class Action Over Medical Device Safety Issues – BFA Law Reminds Investors of the November 3 Deadline |
Globe Newswire |
10/30 |
06:18 |
| CC Lawsuit Reminder: Chemours Hit with Securities Fraud Class Action Over Opteon Demand Issues – BFA Law Reminds Investors of the December 7 Deadline |
Globe Newswire |
10/30 |
06:18 |
